Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Dalton, Cerium Ink Development & Mfg. Agreement | Contract Pharma

What are you searching for?

Sign in
Breaking News

Dalton, Cerium Ink Development & Mfg. Agreement

Will provide formulation development, liquid filling, analytical method validation, QC testing and ICH stability services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dalton Pharma Services has entered a drug development and manufacturing services agreement with Cerium Pharmaceuticals, Inc., an emerging biopharma company focused on rare diseases based in Gaithersburg, MD.
 
Dalton will provide formulation development, cGMP liquid filling, analytical method validation, quality control release testing and ICH stability services to support of Cerium’s drug development program.
 
“Our expert capabilities in formulation development and sterile fill/finish of APIs combined with our strength in cGMP API manufacturing has led to the signing of this important drug development and manufacturing agreement,” said Peter Pekos, president and chief executive officer. “We are excited to have this opportunity and look forward to participating in Cerium’s drug development program, which has great promise for providing a therapy for a major unmet medical need.”
 
Gregg Lapointe, chief executive officer of Cerium said, “Dalton is an excellent fit for our needs, and we are delighted to be partnering with a company whose client focus and commitment to quality match our own.  Cerium will benefit greatly from having Dalton’s facilities, experience, technical expertise and array of integrated services to move our drug from R&D to cGMP manufacturing.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics